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Data on the extent of the burden due to schistosomiasis is sparse in most Sub-Saharan African countries. However,
this data is crucial for triggering medical attention. A review of extent of morbidity and determinants associated
with schistosomiasis in Malawi was therefore conducted to quantify the infection in order to concretise the need
for medical intervention. A systematic and traditional search strategy was used to find literature for the review,
whilst exclusion and inclusion criteria were used to identify appropriate articles. Logistic regression curves of
epidemiological model Y = (a + bxc)/(1 + bxc) and the recommendation that schistosomiasis prevalence can be
used to estimate morbidity were employed to quantify morbidity at various infection stages. Morbidity was
quantified as a direct proportion of the population and the respective national schistosomiasis prevalence. Findings
showed that both S. mansoni and S. haematobium are present in Malawi with the latter highly prevalent (50%).
Furthermore, out of the estimated population of 16,829 million, approximately 8.4 million have schistosomiasis, with
about 4.4 million of these aged 18 years and below. The most frequent manifestation is Katayama syndrome, while
ascites is the lowest, impacting about 3.0 million and 960 individuals, respectively. Localised studies on association
of schistosomiasis infection to risk factors such as occupation, age and gender found odds ratio (OR) ranging from
1.29 to 5.37. Morbidity due to schistosomiasis is high in Malawi. It is therefore recommended that a more detailed
study on the determinants of high schistosomiasis and re-evaluation of the current control measures be conducted
if the current morbidity statistics are to be remarkably reduced.
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stract into the six official working languages of the
United Nations.Introduction
There are both urinary and intestinal schistosomiasis
present in Malawi, but their prevalences vary widely in
space and magnitude [1,2]. Despite the existence of the
disease, officially harmonised morbidity, mortality, or as-
sociated mortality and morbidity data are not readily
available. This paper is a review of the relevant studies
conducted on schistosomiasis in Malawi with special
focus on morbidity, prevalence and determinants (risk* Correspondence: amtethiwa@bunda.luanar.mw
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unless otherwise stated.factors, and knowledge, attitude and practices [KAP]) of
the disease.
Malawi is a country located in Southern Africa and oc-
cupies an area of approximately 119,000 km2. It has an
estimated population of 16,829 million [3,4]. The coun-
try is bordered by Zambia in the west, Tanzania in the
north and northeast, and Mozambique in the east, south
and southwest. It is subdivided into three administrative
regions: Southern, Central and Northern [3].
Schistosomiasis, also known as bilharziasis or bilharzia
[5], is one of the chronic parasitic diseases caused by di-
genetic trematodes of the genus Schistosoma. Humans
can acquire it through contact with cercariae-infested
freshwaters. It is endemic in 78 countries and is caused
by at least seven schistosome species which include
S. haematobium, S. mansoni, S. japonicum, S. intercalatum,
S. malayensis, S. mekongi and S. sinensium [5,6]. Schisto-
soma haematobium and S. mansoni are the two species
most endemic in Sub-Saharan Africa causing urinary andral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Biomphalaria species are the intermediate host snails for
S. haematobium and S. mansoni, respectively [8].
The life cycle requires surface freshwater in which the
parasite eggs from infected humans will hatch into mira-
cidia. The miracidia penetrate an appropriate aquatic
snail where they mature into cercariae. The cercariae
then leaves the snail and penetrates the human skin and
develops inside the body to maturity [9,10]. The matured
schistosomes have separate sexes and the male body has
a groove where the female is held for the rest of its life,
releasing fertilised eggs [10]. Among the common signs,
intestinal schistosomiasis causes fatigue, abdominal pain,
diarrhoea and blood-stained stools, while urinary schis-
tosomiasis causes dysuria, frequent urination and ter-
minal haematuria [11]. Schistosomiasis can be diagnosed
microscopically by examining schistosome eggs in the
stool (S. mansoni) or urine (S. haematobium) [12]. In
addition, urinary schistosomiasis can be detected by the
presence of blood in the urine and intestinal schistosom-
iasis by blood in the stool [9]. A number of the symp-
toms and signs of schistosomiasis infection are common
to other diseases, and as such, it is not easy to isolate
and estimate the extent to which schistosomiasis can
cause morbidity in the human population [13]. It is with
this background that this review was conducted to quan-
tify the morbidity due to schistosomiasis in Malawi.
Review
An integrated literature search, comprising traditional
and systematic literature search and review approaches,
was used. The retrieved literature was screened and
synthesised according to a set of predetermined criteria.
The systematic literature search was conducted using
PubMed, Global Health, HINARI and World Health
Organization (WHO) databases and relevant journals,
whilst a traditional literature search collected informa-
tion from different institutions, Google, bibliographies of
identified papers and grey literature. Institutions that
were consulted in Malawi included the Ministry of
Health (MoH), the Bilharzia Control Programme office,
College of Medicine Library and various individuals. A
decision tree for inclusion and exclusion of articles was
used, as described in [14] and outlined in Figure 1.
Screening of relevant articles
Inclusion and exclusion criteria were used to select articles
to include in the review. These were based on dates, lan-
guages, titles and content. The search included articles writ-
ten in English between 1970 and 2014. Studies conducted
either in Malawi or within the Malawi region, or with inter-
national coverage but that had relevant information to this
review, were selected. Forty-six articles were identified and
of these, 18 met the inclusion criteria. To identify relevantstudies, text strings ‘Bulinus/Biomphalaria or Malawi’,
‘S. haematobium or Malawi’, ‘S. mansoni or Malawi’, ‘burden
or Malawi’, ‘prevalence’, ‘Malawi’ or ‘schistosom*’ and ‘urinary’
or ‘Malawi’ were used.
Literature was screened in two phases. The first phase
was based on titles and abstracts of the retrieved articles,
whilst the second stage was applied to studies that
passed the first phase and focused on content, method-
ology and outcomes. Full-text papers that passed the
second stage were reviewed and interpreted against the
objectives of this review. The final list of the identified
studies/articles on schistosomiasis is outlined in Table 1.
Occurrence and prevalence
Schistosomiasis has been endemic in Malawi for decades
[15] and has been recognised for more than 80 years [16].
Current statistics show high infection rates in children aged
between five and 15 years, with prevalences of 90–100% in
highly endemic areas. This is due to children’s higher ex-
posure and dependence on the infected water bodies, as
well as the fact that children are less resistant than adults
because of the children’s low exposure to worm antigens
[17-19]. Currently in Malawi, it is estimated that the na-
tional prevalence for schistosomiasis is between 40% and
50% [17], as reported in [18,20]. However, other findings
show that 80% of the Malawian population is at risk of
infection with most of those infected living in rural areas
[17]. Research has shown that there has been a sharp in-
crease in prevalence from the mid-1980 along the lakeshore
areas of Lake Malawi [21]. Furthermore, Chitipa, Karonga,
Nkhata Bay, Kasungu, Nkhotakota, Salima, Mangochi,
Machinga, Zomba, Chikwawa and Nsanje are districts that
have recorded high prevalences [22]. High prevalence rates
are presumably enhanced by either their proximity to large
water bodies (lakes and rivers), rice farming and sources of
water for domestic use [14]. Consequently, most of the dis-
tricts in Malawi do not have local estimates [2].
Literature further revealed that in Malawi, S. haemato-
bium is highly prevalent and more predominant in the
southern region, while S. mansoni is more prevalent in
the central and the northern regions [15]. This can be
due to variations in the abundance and distribution of
the Biomphalaria and Bulinus snail, which is an effect of
selective introductions and climatic factors within differ-
ent ecological zones [23]. Multiple/mixed infections with
S. haematobium and S. mansoni, hookworms and Ascaris
have been reported in a number of studies, with a preva-
lence of about 12% [1,18]. However, prevalence in commu-
nal water reservoirs has not been adequately documented.
The burden of schistosomiasis in Malawi
Recent global findings rank schistosomiasis as one the
25 leading diseases [24]. In Malawi, schistosomiasis
is among the top 20 diseases causing high outpatient
Figure 1 Decision tree showing inclusion and exclusion criteria for identifying of studies.
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ease ranks second only to malaria among the parasitic
diseases in terms of the number of people infected and
at risk in endemic areas [22,25]. It leads to a loss of
1.7–4.5 million disability-adjusted life years (DALYs) in
the world [6]. Consequently, schistosomiasis contributes
approximately 0.1% and 0.4% to the Sub-Saharan Africa
and global disease burden, respectively [13]. However,
considering the large number of people that are infected,
the small estimated contribution by schistosomiasis to
the disease burden may not be a true reflection, and
may be masked by the immerse burden of HIV/AIDS,
malaria, childhood diseases, diarrhoeal diseases and tu-
berculosis [13]. Furthermore, isolating morbidity caused
by schistosomiasis from that caused by other diseases is
complicated [2]. One method to achieve this is to iden-
tify all diseases that cause a certain common morbidity
in a population and treat each separately. The morbidity
rate that remains can then be attributed to schistosomia-
sis. A complication again arises as some of the drugs are
active against several morbidities and/or diseases. The
burden of schistosomiasis has not been determined in
Malawi using DALYs.
Based on the current population of 16 million and a
schistosomiasis prevalence of 50% [17,20], it can be esti-
mated that about eight million people are infected in
Malawi. It further translates that about 7.2 million of the
infected population are found in rural areas since about
90% of Malawians live in these areas [3]. Approximately
4.2 million (52%) of the infected population is aged 18 years
and below because 52% of the Malawi population is within
that age range [3]. The implication of this is that the
country will end up with a sick, unproductive gener-
ation if schistosomiasis patients are not treated on time.
Amongst school-age children, prevalence is higher in
males than in females due to behavioural and occupationalvariabilities that lead to differences in the frequency of
visits to water bodies. Studies have shown that those
who frequent water bodies for various activities are at a
higher risk of contracting the disease than their non-
visiting counterparts [2].
Morbidity
Morbidity is a non fatal outcome while mortality is a fatal
outcome of an ailment [4,13,26]. Schistosomiasis morbid-
ity exhibits in various stages, as shown in Table 2.
Using a relationship (regression) modela: Y = (a + bxc)/
(1 + bxc), which stipulates that prevalence of a specific
morbidity is a function of prevalence of the national schis-
tosomiasis infection [26], and a recommendation that
‘prevalence of an infection is the only readily available epi-
demiological parameter that can be used to estimate mor-
bidity’ [13], the prevalence of a specific morbidity at each
stage of schistosomiasis infection can be estimated. The
proportion of individuals with a specific morbidity is esti-
mated from the community or national prevalence rates,
as outlined in Table 3.
Based on the national prevalence of 50% and 10% for
S. haematobium and S. mansoni, respectively [2,20], and
subsequent proportions outlined in Table 3, the number
of individuals with specific schistosomiasis morbidity is
estimated and presented in Table 4. The estimates show
that in Malawi, there are about 2.5 million people inflicted
with Katayama and about two million with haematuria.
However, Van der Werf [26] estimated that 20% (3.2 mil-
lion) of the Malawi population experience schistosomiasis-
related dysuria and haematuria. The estimate by this study
is lower than that estimated by Van der Werf [26]. The
difference could be as results of disease intervention over
the 10 years after the estimate. Besides this, considering
that 52% of Malawians are below 18 years of age, it can be
said that more that half of those inflicted by these ailments
Table 1 List of articles that met the inclusion criteria for the review
SN Topic Year Region Sample size Burden (DALYs) Morbidity Mortality Prevalence
A1 Schistosomiasis Morbidity and
management cases in Africa
2003 Africa (Review paper) – 1.3 – – 0-89
A2 Global burden of diseases due
to schistosomiasis
2003 World (Review paper – 1.7 220,000 – –
A3 National survey on the prevalence
of schistosomiasis and soil helminths
in Malawi
2004 Malawi 1,664 – – – 6.9
A4 Prevalence, distribution and risk factors
of S. haematobium infection in
schoolchildren in Blantyre Malawi
2009 Malawi, Blantyre 1,139 – – – 0-46
A5 Schistosomiasis and water resources
development: systematic review,
meta-analysis, and estimates of
people at risk
2006 Africa (review paper) – 4.7 – – 0-67
A7 Schistosomiasis Control Programme -
Community Health Surveillance Unit
(1997–2001): Lakeshore Schistosomiasis
Control Project.
2001 Malawi – – – – 40-50
A8 Analysis of Schistosomiasis haematobium
Infection Prevalence and Intensity in
Chikhwawa, Malawi: An Application of a
Two Part Model.
2013 Malawi, Chikhwawa 1642 – – – 14.3
A9 2008 Population and housing census,
Minister of Economic Planning and
Development, National Statistical
Office, Malawi.
2008 Malawi ~14,000,000 – – – –
A10 The schistosomiasis intermediate host
Bullinus nyassanus is a preferred food
for cichlid fish-Tramacranus placodon
at Cape Maclear, Lake Malawi.
2006 Malawi, Mangochi – – – –
A11 National Survey to find out difficulties
people face in taking regular
antischistosomal drugs in Malawi.
2003 Malawi – – – – –
A12 The burden of disease in Malawi. 2006 Malawi – – – – –
A13 Measuring the global burden of disease 2013 187 countries
(A review paper)
– 1.7-4.7 – – 0-67
A14 Schistosomiasis in Lake Malawi 1994 Malawi – – – – 32
A15 Schistosomiasis in Lake Malawi and
the Potential Use of Indigenous Fish
for Biological Control
2012 Malawi 487 – – – 43
A16 Schistosomiasis in Lake Malawi Villages 2011 Malawi 487 – – – 94
A17 Bulinus nyassanus is an intermediate
host for Schistosoma haematobium
in Lake Malawi
2001 Malawi – – – – –
A18 Sentinel surveillance of Lymphatic
filariasis, Schistosomiasis, Soil
transmitted helminths and Malaria
in rural southern Malawi
2010 Malawi 1,903 – – – 94
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estimates of mortality caused by schistosomiasis could not
be calculated.
Control strategies for schistosomiasis
A number of measures are employed aimed at preventing
new infections, usually by interrupting the parasite’s lifecycle [27]. This has been done by using methods that ei-
ther eliminate the intermediate host or the parasite from
the definitive host, or prevent infection of the definitive
host or of the intermediate host [9,21,22,28]. Apart from
the chemotherapy intervention, an integrated approach is
employed where several control measures are combined.
An essential component of the integrated control strategy,
Table 2 Schistosomiasis morbidity at various infection stages
Stage Pathology Morbidity due to S. mansoni Morbidity due to S. haematobium
Invasion Cercarial dermatitis Cercarial dermatitis
Acute As a result of antigens and
metabolites excreted with
egg production
Katayama fever, weakness, weight
loss, headache, anorexia, nausea,




Katayama fever, chills, weakness,
weight loss, headache, haematuria,
pain on micturition, urinary dribbling
and incontinence,
Early Colonic focal fibrosis and
granulomatous inflammation
(Bloody) diarrhoea, blood in stool,
abdominal pain
haematuria
Early and late Anaemia




Bladder cancer, obstructive uropathy,
hydronephrosis, renal parychyma
impared, kidney disfunction
Subtle Ectopic lesions (CNS) Convulsions, paralysis, reduction
of growth, impaired cognitive
development, reduced physical fitness
Uropathy, kidney failure
Mortality Portal hypertension Liver failure, corpulmonale Haematemesis Kidney failure, ascetic renal failure,
bladder cancer, kidney necrosis
Source: [9,26,40,41].
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health care to patients in hospitals [29].
Elimination of intermediate host snails
In Malawi, there is sketchy information on the biological
and chemical approaches for the control of the intermedi-
ate host snail. Biologically, the Trematocranus placodon fish
of the family Cichlidae, which feeds on Bulinus and Biom-
phalaria snails species, has been studied and used to con-
trol snails on an experimental basis, however, results haveTable 3 Estimates of morbidity ratios at respective
schistosomiasis prevalence
Morbidity/infection 0.15 0.50 0.85
S. mansoni
Katayama 0.012 0.002 0.091
Diarrhoea 0.0001 0.001 0.072
Blood stool 0.001 0.02 0.24
Hepatomegaly (MSL) 0.01 0.07 0.14
Hepatomegaly (MCL) 0.01 0.06 0.12
Splenomegaly 0.011 0.047 0.089
Haematemesis ever 0.002 0.006 0.011
Ascites 0.0004 0.0012 0.0021
S. haematobium
Katayama 0.062 0.232 0.387
Haematuria 0.031 0.197 0.349
Incontinence 0.011 0.047 0.089
Bladder cancer 0.01 0.06 0.12
Kidney failure 0.01 0.07 0.14
Source: [13,24,26].not been remarkable [21,30]. Decline in the T. placodon
population due to heavy artisanal fishing and its possible
preference for soft foods to snails have been indicated as
the setbacks for the success of the intervention [30]. Unless
research on this is intensified, its application in the field in
Malawi remains uncertain.
Use of molluscicides in Malawi has been largely on indi-
vidual farms, especially fishponds, with no formal docu-
mentation on its implementation, coverage and success.Table 4 Number of individuals with various S. haematobium
and S. mansoni morbidity in Malawi at respective
prevalence*
















*Morbidity = morbidity ratio (at respective national schistosomiasis prevalence)
x number of individual infected by schistosomiasis.
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number of major shortfalls among which are severe toxicity
non-target soft bodied aquatic organisms [31]. Niclosamide
is the only commercially available molluscicides recom-
mended by the WHO for large-scale use in schistosomiasis
control programmes [27,32].
Chemotherapy
In Malawi, 60% of the health services are provided by the
Ministry of Health and Population, 37% by the Christian
Health Association of Malawi (CHAM), 1% by the Minis-
try of Local Government and 2% by other providers [3,22].
Chemotherapeutically, praziquantel has been used for
years to treat and control schistosomiasis in Malawi. How-
ever, studies have shown that 30% of the population can-
not access the drug [22]. This is because the drug is either
not available at government health units, is expensive in
the private pharmacies, or that long distances discourage
and preclude people from getting to the government
health units where the drug is provided [22,30]. Beside
this, like in other countries, free drugs are mostly available
to school children only [22,33]. Despite this, the Malawi
National Schistosomiasis Control Programme does not
have well-documented evidence of when and where the
universal drug treatment has been offered [1]. One of the
problems with this approach is re-infection that can hap-
pen after visiting the cercariae-infested waters after treat-
ment, a probable problem in the country.
Social determinants of schistosomiasis infection
The community’s knowledge, attitudes and practices (KAP)
and risk factors influence acquisition, transmission and thus
persistence of schistosomiasis in the community [34]. As
such, a good understanding of local KAP is central to the de-
velopment of effective control measures that would thwart
further transmission [15]. Communities, especially children,
lack understanding on the transmission of schistosomiasis
[15,33]. In Tanzania, for instance, the prevalence of the dis-
ease remained as high as 62%, although 82% of the children
were treated for it [35]. This may be attributed to a lack of
knowledge on the transmission of schistosomiasis and un-
changed behaviour in many of the school children [35,36].
Studies have unveiled that communities perceive schis-
tosomiasis as a normal physiological development in
growing children, a disease that recurs however you treat
it, a disease for males, a sexually transmitted disease and
as a disease better treated with herbs [34,35,37]. In light of
these attitudes, it is unlikely that patients will seek treat-
ment from hospitals [33]. In essence, KAP on schistosom-
iasis has not been adequately studied in Malawi.
Risk factors
Localised studies in Malawi identified occupation, age,
education, gender, socioeconomic status, proximity andfrequency of visits to water bodies or sources of water as
common risk factors [2,18]. Furthermore, studies found
a strong association of prevalence and risk factors, with
an OR ranging from 1.72 to 5.39 [2]. These findings
mean that these factors would determine the level of ac-
quisition of schistosomiasis in Malawi.
Snail intermediate hosts
The distribution of schistosomiasis is determined, to a
larger extent, by the presence or absence of snail inter-
mediate hosts [23]. In Malawi, Biomphalaria and Buli-
nus have been identified, and at least studied, in the
Lake Malawi ecosystems [38]. Bulinus nyassanus, one of
the intermediate host for S. haematobium [39] is en-
demic to Lake Malawi and is found on open sandy areas
without macrophytes, usually buried 2–3 cm into the
gravel. Another snail that is an intermediate host for
S. haematobium and is most common among aquatic
plants is B. globosus. Although it is uncommon in Lake
Malawi, it has been reported in several sites in the lake, es-
pecially near inflowing streams [39]. However, there is
scanty information on the distribution, seasonality and in-
fectivity of host snails in the communal water reservoirs.
Conclusion
This review has unveiled alarming schistosomiasis mor-
bidity statistics in Malawi amidst years of chemothera-
peutical intervention. It has further revealed that risk
factors, and knowledge, attitude and practices on schis-
tosomiasis have not been adequately explored. It is
expected that more information about the disease in
the country will be disclosed as more studies are being
conducted. Re-evaluation of the current control mea-
sures and implementation of integrated targeted and
effective schistosomiasis control measures are recom-
mended if the current morbidity statistics are to be re-
markably reduced.
Study limitations
Whilst every effort was made to gather all the relevant
documents and information, a number of grey literatures
on KAP for the study, including those conducted by the
Danish Bilharzia Laboratory around the 1990s, could not
be accessed. This is because the literature is not readily
available in the public domain. However, since this re-
view mostly focused on the quantification of morbidity
and the rest of the information is only supportive, the
absence of this literature would not significantly change
the outcome of this review.
Endnote
aY denotes specific morbidity; x denotes schistosomiasis
infection; a denotes prevalence due to other diseases;
b and c denote degree of association where b = (c–1)/(c + 1).
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